USE OF DILTIAZEM FOR THE TREATMENT OF PATHOLOGIES OF THE NETWORK

摘要

The invention concerns the use of a calcium channel blocker compound and/or cyclic GMP-dependent channels, namely diltiazem, for treating retinal pathologies, and more particularly retinal diseases caused by degeneration of visual receptors, in a human or animal.